---
schema_version: "secwatch.filing_event.v1"
accession: "0001683168-23-007115"
form_type: "8-K"
ticker: "ZSQR"
cik: "0001759186"
company_name: "Z Squared Inc."
filed_at: "2023-10-13T23:59:59+00:00"
generated_at: "2026-06-10T00:06:34.650688+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.55
calibrated_materiality_score: 0.55
confidence: "high"
source: SEC EDGAR
---

# Coeptis Therapeutics issues 3M shares to two investors for $3M; $500k cash, $2.5M notes due 2024

## Summary
- Issued 2.4M shares to Biofin Ventures for $2.4M ($400k cash + $2M promissory note due Aug 2024).
- Issued 600k shares to AG Bio Life Capital I for $600k ($100k cash + $500k note due Aug 2024).
- Notes bear 6% interest (18% on default), payable by Aug 30, 2024; investors may prepay.
- If Biofin or AG sell shares before maturity, proceeds from sales must be contributed to the company.
- Unregistered issuance dilutes existing shareholders by ~3M shares; only $500k received upfront.

## SEC filing metadata
- accession: 0001683168-23-007115
- form_type: 8-K
- ticker: ZSQR
- cik: 0001759186
- company_name: Z Squared Inc.
- filed_at: 2023-10-13T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.55
- calibrated_materiality_score: 0.55
- confidence: high
- sec_items: 3.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1759186/000168316823007115/0001683168-23-007115-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1759186/000168316823007115/coeptis_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001683168-23-007115
- JSON: https://secwatch.observer/filing/0001683168-23-007115.json
- Plain text: https://secwatch.observer/filing/0001683168-23-007115.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.